Literature DB >> 34073394

Control of Tumor Progression by Angiocrine Factors.

Elisenda Alsina-Sanchis1, Ronja Mülfarth1,2, Andreas Fischer1,3,4.   

Abstract

Tumor progression, therapy resistance and metastasis are profoundly controlled by the tumor microenvironment. The contribution of endothelial cells to tumor progression was initially only attributed to the formation of new blood vessels (angiogenesis). Research in the last decade has revealed however that endothelial cells control their microenvironment through the expression of membrane-bound and secreted factors. Such angiocrine functions are frequently hijacked by cancer cells, which deregulate the signaling pathways controlling the expression of angiocrine factors. Here, we review the crosstalk between cancer cells and endothelial cells and how this contributes to the cancer stem cell phenotype, epithelial to mesenchymal transition, immunosuppression, remodeling of the extracellular matrix and intravasation of cancer cells into the bloodstream. We also address the long-distance crosstalk of a primary tumor with endothelial cells at the pre-metastatic niche and how this contributes to metastasis.

Entities:  

Keywords:  angiocrine; blood vessels; cancer; endothelial cells; metastasis; tumor progression

Year:  2021        PMID: 34073394     DOI: 10.3390/cancers13112610

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  121 in total

1.  Transendothelial migration of colon carcinoma cells requires expression of E-selectin by endothelial cells and activation of stress-activated protein kinase-2 (SAPK2/p38) in the tumor cells.

Authors:  J Laferriere; F Houle; M M Taher; K Valerie; J Huot
Journal:  J Biol Chem       Date:  2001-07-11       Impact factor: 5.157

2.  Normalization of Tumor Vessels by Tie2 Activation and Ang2 Inhibition Enhances Drug Delivery and Produces a Favorable Tumor Microenvironment.

Authors:  Jin-Sung Park; Il-Kug Kim; Sangyeul Han; Intae Park; Chan Kim; Jeomil Bae; Seung Ja Oh; Seungjoo Lee; Jeong Hoon Kim; Dong-Cheol Woo; Yulong He; Hellmut G Augustin; Injune Kim; Doheon Lee; Gou Young Koh
Journal:  Cancer Cell       Date:  2017-01-09       Impact factor: 31.743

3.  Vascular endothelial growth factor induces proliferation of breast cancer cells and inhibits the anti-proliferative activity of anti-hormones.

Authors:  Yayun Liang; Rolf A Brekken; Salman M Hyder
Journal:  Endocr Relat Cancer       Date:  2006-09       Impact factor: 5.678

4.  Potent Activity of an Anti-ICAM1 Antibody-Drug Conjugate against Multiple Myeloma.

Authors:  Daniel W Sherbenou; Yang Su; Christopher R Behrens; Blake T Aftab; Olivia Perez de Acha; Megan Murnane; Shelby C Bearrows; Byron C Hann; Jeffery L Wolf; Thomas G Martin; Bin Liu
Journal:  Clin Cancer Res       Date:  2020-09-11       Impact factor: 12.531

5.  Crossing the endothelium: E-selectin regulates tumor cell migration under flow conditions.

Authors:  Julia Woodward
Journal:  Cell Adh Migr       Date:  2008-07-19       Impact factor: 3.405

6.  STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity.

Authors:  Olivier Demaria; Aude De Gassart; Sanja Coso; Nicolas Gestermann; Jeremy Di Domizio; Lukas Flatz; Olivier Gaide; Olivier Michielin; Patrick Hwu; Tatiana V Petrova; Fabio Martinon; Robert L Modlin; Daniel E Speiser; Michel Gilliet
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-25       Impact factor: 11.205

7.  Vascular niche IL-6 induces alternative macrophage activation in glioblastoma through HIF-2α.

Authors:  Qirui Wang; Zhenqiang He; Menggui Huang; Tianrun Liu; Yanling Wang; Haineng Xu; Hao Duan; Peihong Ma; Lin Zhang; Scott S Zamvil; Juan Hidalgo; Zhenfeng Zhang; Donald M O'Rourke; Nadia Dahmane; Steven Brem; Yonggao Mou; Yanqing Gong; Yi Fan
Journal:  Nat Commun       Date:  2018-02-08       Impact factor: 14.919

8.  Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC.

Authors:  Mark A Socinski; Robert M Jotte; Federico Cappuzzo; Francisco Orlandi; Daniil Stroyakovskiy; Naoyuki Nogami; Delvys Rodríguez-Abreu; Denis Moro-Sibilot; Christian A Thomas; Fabrice Barlesi; Gene Finley; Claudia Kelsch; Anthony Lee; Shelley Coleman; Yu Deng; Yijing Shen; Marcin Kowanetz; Ariel Lopez-Chavez; Alan Sandler; Martin Reck
Journal:  N Engl J Med       Date:  2018-06-04       Impact factor: 91.245

9.  Endothelial cells promote metastasis of prostate cancer by enhancing autophagy.

Authors:  Ruizhe Zhao; Xiaoyu Bei; Boyu Yang; Xiaohai Wang; Chenyi Jiang; Fei Shi; Xingjie Wang; Yiping Zhu; Yifeng Jing; Bangmin Han; Shujie Xia; Qi Jiang
Journal:  J Exp Clin Cancer Res       Date:  2018-09-10
View more
  3 in total

1.  Liver Endothelium Promotes HER3-Mediated Cell Survival in Colorectal Cancer with Wild-Type and Mutant KRAS.

Authors:  Moeez Rathore; Wei Zhang; Michel'le Wright; Rajat Bhattacharya; Fan Fan; Ali Vaziri-Gohar; Jordan Winter; Zhenghe Wang; Sanford D Markowitz; Joseph Willis; Lee M Ellis; Rui Wang
Journal:  Mol Cancer Res       Date:  2022-06-03       Impact factor: 6.333

Review 2.  (Im)maturity in Tumor Ecosystem.

Authors:  Keywan Mortezaee; Jamal Majidpoor
Journal:  Front Oncol       Date:  2022-01-25       Impact factor: 6.244

Review 3.  LRG1: an emerging player in disease pathogenesis.

Authors:  Carlotta Camilli; Alexandra E Hoeh; Giulia De Rossi; Stephen E Moss; John Greenwood
Journal:  J Biomed Sci       Date:  2022-01-21       Impact factor: 12.771

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.